Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,376 | 275 | 95.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $200.00 | 1 | 3.6% |
| Education | $45.42 | 5 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,568 | 66 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $669.57 | 40 | $0 (2024) |
| Amgen Inc. | $514.64 | 24 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $496.45 | 29 | $0 (2024) |
| Relypsa, Inc. | $446.08 | 43 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $274.49 | 9 | $0 (2024) |
| Vifor Pharma, Inc. | $253.80 | 4 | $0 (2023) |
| CALLIDITAS THERAPEUTICS US INC. | $238.92 | 14 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $178.99 | 10 | $0 (2024) |
| AKEBIA THERAPEUTICS INC | $142.12 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,297 | 65 | AstraZeneca Pharmaceuticals LP ($431.66) |
| 2023 | $1,555 | 77 | AstraZeneca Pharmaceuticals LP ($620.48) |
| 2022 | $840.53 | 41 | AstraZeneca Pharmaceuticals LP ($357.96) |
| 2021 | $265.54 | 6 | Vifor Pharma, Inc. ($204.85) |
| 2020 | $198.12 | 11 | AstraZeneca Pharmaceuticals LP ($77.84) |
| 2019 | $917.97 | 51 | Relypsa, Inc. ($271.70) |
| 2018 | $344.73 | 26 | Fresenius USA Marketing, Inc. ($141.62) |
| 2017 | $202.78 | 4 | Keryx Biopharmaceuticals, Inc. ($137.93) |
All Payment Transactions
281 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $10.32 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/12/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $5.74 | General |
| Category: Nephrology | ||||||
| 12/03/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Nephrology | ||||||
| 12/03/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $1.72 | General |
| Category: Nephrology | ||||||
| 12/03/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $0.70 | General |
| Category: Nephrology | ||||||
| 11/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/19/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: NEPHROLOGY | ||||||
| 11/15/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $33.82 | General |
| Category: Inflammation | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $25.63 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/22/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Nephrology | ||||||
| 10/18/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: NEPHROLOGY | ||||||
| 10/04/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $28.60 | General |
| Category: IMMUNOLOGY | ||||||
| 10/03/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $6.70 | General |
| Category: Nephrology | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $27.59 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/27/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $20.79 | General |
| 09/27/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $20.44 | General |
| 09/26/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 09/25/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $28.53 | General |
| Category: Nephrology | ||||||
| 09/21/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $33.90 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/15/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: Inflammation | ||||||
| 08/14/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $29.55 | General |
| Category: Nephrology | ||||||
| 08/09/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 290 | 893 | $325,212 | $173,728 |
| 2022 | 8 | 325 | 1,054 | $373,252 | $199,668 |
| 2021 | 7 | 352 | 1,218 | $387,061 | $214,771 |
| 2020 | 6 | 287 | 654 | $134,093 | $75,538 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 36 | 292 | $175,200 | $90,738 | 51.8% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 28 | 98 | $49,000 | $25,386 | 51.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 65 | 239 | $40,897 | $25,207 | 61.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 79 | 165 | $28,875 | $17,836 | 61.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 46 | 60 | $19,500 | $9,224 | 47.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 23 | 23 | $9,200 | $4,327 | 47.0% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 13 | 16 | $2,540 | $1,009 | 39.7% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 39 | 333 | $199,800 | $105,231 | 52.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 85 | 354 | $63,394 | $32,167 | 50.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 73 | 91 | $29,783 | $15,835 | 53.2% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 12 | 60 | $24,000 | $15,690 | 65.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 62 | 131 | $22,925 | $14,156 | 61.8% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 19 | 45 | $22,500 | $11,762 | 52.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 18 | 18 | $7,200 | $3,406 | 47.3% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 17 | 22 | $3,650 | $1,420 | 38.9% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 44 | 383 | $217,200 | $122,403 | 56.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 110 | 496 | $85,963 | $45,646 | 53.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 76 | 106 | $34,658 | $18,972 | 54.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 64 | 135 | $23,625 | $15,324 | 64.9% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 14 | 19 | $9,100 | $5,009 | 55.0% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 28 | 63 | $10,115 | $4,114 | 40.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 16 | 16 | $6,400 | $3,302 | 51.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 80 | 352 | $55,793 | $33,133 | 59.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 70 | 87 | $29,315 | $15,785 | 53.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 71 | 133 | $23,275 | $12,736 | 54.7% |
About Dr. Josephus-Ian Sanjorjo, MD
Dr. Josephus-Ian Sanjorjo, MD is a Internal Medicine healthcare provider based in Daly City, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2011. The National Provider Identifier (NPI) number assigned to this provider is 1073808168.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Josephus-Ian Sanjorjo, MD has received a total of $5,622 in payments from pharmaceutical and medical device companies, with $1,297 received in 2024. These payments were reported across 281 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($5,376).
As a Medicare-enrolled provider, Sanjorjo has provided services to 1,254 Medicare beneficiaries, totaling 3,819 services with total Medicare billing of $663,705. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Nephrology, Hospitalist
- Location Daly City, CA
- Active Since 06/16/2011
- Last Updated 02/07/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1073808168
Products in Payments
- FARXIGA (Drug) $1,100
- Veltassa (Drug) $699.88
- Velphoro (Drug) $669.57
- ACTHAR (Biological) $496.45
- LOKELMA (Drug) $467.87
- JYNARQUE (Drug) $278.92
- KRYSTEXXA (Biological) $244.78
- TARPEYO (Drug) $238.92
- Parsabiv (Biological) $198.90
- Kerendia (Drug) $178.99
- Auryxia (Drug) $150.47
- AURYXIA (Drug) $129.58
- JARDIANCE (Drug) $103.85
- Ozempic (Drug) $102.47
- IBSRELA (Drug) $89.61
- TAVNEOS (Drug) $77.19
- Aranesp (Biological) $57.56
- Edarbi (Drug) $45.88
- JESDUVROQ (Drug) $40.30
- INVOKANA (Drug) $20.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Daly City
Kevin Wong, M.d, M.D
Internal Medicine — Payments: $45,517
Tony Wong, M.d, M.D
Internal Medicine — Payments: $40,235
Dr. John Lai, M.d, M.D
Internal Medicine — Payments: $39,667
Dr. Alice Yan, M.d, M.D
Internal Medicine — Payments: $22,968
Damon Lee, Md, MD
Internal Medicine — Payments: $20,608
Dr. Shu May Lee, M.d, M.D
Internal Medicine — Payments: $18,620